Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM INFLUENCES RISK OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION

View through CrossRef
Objective: Renin-angiotensin aldosterone system plays a major role in blood pressure regulation. Aldosterone, synthesized in the adrenal cortex by aldosterone synthase is encoded by the cytochrome 11B2 aldosterone synthase gene (CYP11B2). The aim of the study was to analyze the association of aldosterone synthase gene (CYP11B2) biallelic polymorphism (-344C/T) with Chronic Kidney Disease (CKD) in patients with essential arterial hypertension (EAH) in West-Ukrainian population. Design and method: One-hundred subjects with EAH and target-organ damaging (2nd stage), moderate, high or very high cardiovascular risk were involved in the case-control study. Among them 79.0% (79) females and 21.0% (21) males, mean age 59.87 ± 8.02 yo; disease duration from 6 to 25 years. CKD was determined by the National Kidney Foundation recommendations (Kidney Disease: Improving Global Outcomes (KDIGO), 2012) after glomerular filtration rate (GFR) decline < 60 ml/min/1.73sq.m for over 3 months (by Cockroft-Gault formula and CKD-EPI for Cystatin-C and Creatinine serum levels depending on gender). CKD was diagnosed in 29 persons. All enrolled / screened patients signed the Informed Consent to participate in the research. Control group included 48 practically healthy persons of relevant age. Gene polymorphism of aldosterone synthase gene CYP11B2 (-344C/T) was examined by polymerase chain reaction (PCR). Results: The probability of EAH in observed population increased 1.49 times in T-allele carriers of CYP11B2 gene, but only in females [OR = 1.90; 95%CI:1.02–3.54; p = 0.029], with contrary decreasing in C-allele women (p = 0.041). No relevant dependences were observed in hypertensive males. Also T-allele increased probability of CKD (GFR< 60 ml/min/1,73m2) in hypertensive population 1.48 times [OR = 1.86; 95%CI:1.01–3.58; p = 0.049], especially in T-allele females 1.53 times [OR = 6.51; 95%CI:1.39–30.60; p = 0.007] with low CKD risk in T-allele males [OR = 0.15; 95%CI:0.03–0.72; p = 0.009], respectively. Some predictors like DM2, the 2nd and 3rd grades of Obesity, and the 3rd grade level of Blood Pressure elevation escalated the risk of CKD 2.4, 2.08–2.32 and 2.91 times, accordingly (p< 0.05). Conclusions: Aldosterone synthase gene CYP11B2 (-344C/T) is associated with EAH. T-allele increased risk of CKD in hypertensive population, especially in females.
Title: ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM INFLUENCES RISK OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION
Description:
Objective: Renin-angiotensin aldosterone system plays a major role in blood pressure regulation.
Aldosterone, synthesized in the adrenal cortex by aldosterone synthase is encoded by the cytochrome 11B2 aldosterone synthase gene (CYP11B2).
The aim of the study was to analyze the association of aldosterone synthase gene (CYP11B2) biallelic polymorphism (-344C/T) with Chronic Kidney Disease (CKD) in patients with essential arterial hypertension (EAH) in West-Ukrainian population.
Design and method: One-hundred subjects with EAH and target-organ damaging (2nd stage), moderate, high or very high cardiovascular risk were involved in the case-control study.
Among them 79.
0% (79) females and 21.
0% (21) males, mean age 59.
87 ± 8.
02 yo; disease duration from 6 to 25 years.
CKD was determined by the National Kidney Foundation recommendations (Kidney Disease: Improving Global Outcomes (KDIGO), 2012) after glomerular filtration rate (GFR) decline < 60 ml/min/1.
73sq.
m for over 3 months (by Cockroft-Gault formula and CKD-EPI for Cystatin-C and Creatinine serum levels depending on gender).
CKD was diagnosed in 29 persons.
All enrolled / screened patients signed the Informed Consent to participate in the research.
Control group included 48 practically healthy persons of relevant age.
Gene polymorphism of aldosterone synthase gene CYP11B2 (-344C/T) was examined by polymerase chain reaction (PCR).
Results: The probability of EAH in observed population increased 1.
49 times in T-allele carriers of CYP11B2 gene, but only in females [OR = 1.
90; 95%CI:1.
02–3.
54; p = 0.
029], with contrary decreasing in C-allele women (p = 0.
041).
No relevant dependences were observed in hypertensive males.
Also T-allele increased probability of CKD (GFR< 60 ml/min/1,73m2) in hypertensive population 1.
48 times [OR = 1.
86; 95%CI:1.
01–3.
58; p = 0.
049], especially in T-allele females 1.
53 times [OR = 6.
51; 95%CI:1.
39–30.
60; p = 0.
007] with low CKD risk in T-allele males [OR = 0.
15; 95%CI:0.
03–0.
72; p = 0.
009], respectively.
Some predictors like DM2, the 2nd and 3rd grades of Obesity, and the 3rd grade level of Blood Pressure elevation escalated the risk of CKD 2.
4, 2.
08–2.
32 and 2.
91 times, accordingly (p< 0.
05).
Conclusions: Aldosterone synthase gene CYP11B2 (-344C/T) is associated with EAH.
T-allele increased risk of CKD in hypertensive population, especially in females.

Related Results

ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
Objectives Aim: To observe aortic and cardiac aldosterone expression and its receptor changes in rats with vascular calcification, and exogenous aldosterone effec...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Expression and polymorphism of genes in gallstones
Expression and polymorphism of genes in gallstones
ABSTRACT Through the method of clinical case control study, to explore the expression and genetic polymorphism of KLF14 gene (rs4731702 and rs972283) and SR-B1 gene (rs...
#1175 Hypertension, diabetes, CKD and acute kidney disorder risk in COVID-19 patients
#1175 Hypertension, diabetes, CKD and acute kidney disorder risk in COVID-19 patients
Abstract Background and Aims Chronic kidney disease (CKD), hypertension and diabetes were the risk factors for acute kidney diso...
The relationship between left ventricular hypervoltage and CYP11B2 (344T/C) polymorphism in Keriyans
The relationship between left ventricular hypervoltage and CYP11B2 (344T/C) polymorphism in Keriyans
Introduction: The ‘desert people’ or Keriyans are able to maintain normal body functions whilst living in the hot, arid areas of Taklimakan Desert. However, little is known about t...
The very elderly followed at a nephrology center: metabolic acidosis as a predictor of progressive chronic kidney disease
The very elderly followed at a nephrology center: metabolic acidosis as a predictor of progressive chronic kidney disease
Chronic kidney disease is an increasingly common diagnosis in the very elderly and identifying the patients who benefit from a nephrologist’s intervention and the ones who would no...

Back to Top